MARCHETTI, SERENA
MARCHETTI, SERENA
Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).
2007 S.MARCHETTI;R.MAZZANTI;JH.BEIJNEM;JHM.SCHELLENS
CLINICAL RELEVANCE:DRUG-DRUG INTERACTION,PHARMACOKINETICS,PHARMACODYNAMICS AND TOXICITY
2007 S.MARCHETTI;R.MAZZANTI;JH.BEIJNEM;JM.SCHELLENS
Effect of ATP-binding cassette drug transporters ABCB1, ABCG2, on erlotinib hydrocloride(Tarceva) disposition in vitro and in vivo pharmacokinetc studies employing Bcrp1-/-/Mdr1a/1b-/-(triple-knockout) and wild type mice.
2008 S. Marchetti; N.A. de Vries;T.Buckle;M.J. Boljin; MA.Eijndhoven; JH. Beijnen; R. Mazzanti; et al.
Hepatocyte Growth Factor and Inducible Nitric Oxide Synthase Are Involved in Multidrug Resistance–Induced Angiogenesis in Hepatocellular Carcinoma Cell Lines
2006 N. LASAGNA; O. FANTAPPIE'; M. SOLAZZO; L. MORBIDELLI; S. MARCHETTI; G. CIPRIANI; M. ZICHE; R. MAZZANTI
In vitro tran sport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2
2008 S.MARCHETTI; RL.OOSTENDORP; D.PLUIM; MA.VAN EIJNDHOVEN; O.VAN TELLINGEN; AH.SCHINKEL; R.VERSACE; JH.BEIJNEN; R.MAZZANTI; JH.SCHELLENS
SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY PERCUTANEOUS ETHANOL INJECTION: A 10-YEAR EXPERIENCE.
2004 R. MAZZANTI; P. PANTALEO; B. NERI; P. GENTILINI; U. ARENA; L. ANTONUZZO; G. CIPRIANI; C. GIORDANO; F. LANINI; S. MARCHETTI
The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate.
2007 OOSTENDORP RL; MARCHETTI S; BEJINEN JH; R. MAZZANTI; SCHELLENS JH. . MAY; -. EPUB AHEAD OF PRINT
Vitamin E protects DNA from oxidative damage in human hepatocellular carcinoma cell lines
2004 O. FANTAPPIE'; M. Lodovici; P. Fabrizio; S. Marchetti; V. Fabbroni; M. Solazzo; N. Lasagna;P. Pantaleo; R. Mazzanti